The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?
出版年份 2015 全文链接
标题
The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?
作者
关键词
-
出版物
Expert Review of Gastroenterology & Hepatology
Volume 9, Issue sup1, Pages 27-34
出版商
Informa UK Limited
发表日期
2015-09-23
DOI
10.1586/17474124.2015.1091307
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity to infliximab is associated with HLA-DRB1
- (2015) Thomas Billiet et al. GUT
- Significance of low level infliximab in the absence of anti-infliximab antibodies
- (2015) Bella Ungar WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial
- (2014) Casper Steenholdt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study
- (2014) D. H. Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- FRI0421 A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study
- (2014) W. Park et al. ANNALS OF THE RHEUMATIC DISEASES
- The biosimilar road in inflammatory bowel disease: The right way?
- (2014) Gionata Fiorino et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- The challenge of indication extrapolation for infliximab biosimilars
- (2014) Brian G. Feagan et al. BIOLOGICALS
- Biosimilars: the science of extrapolation
- (2014) M. Weise et al. BLOOD
- Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis
- (2014) Seung Min Jung et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Physicochemical characterization of Remsima®
- (2014) Soon Kwan Jung et al. mAbs
- Tailoring anti-TNF therapy in IBD: drug levels and disease activity
- (2014) Shomron Ben-Horin et al. Nature Reviews Gastroenterology & Hepatology
- Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
- (2013) Howard Lee AAPS Journal
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
- (2013) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
- (2013) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Late-Breaking Abstracts
- (2013) ARTHRITIS AND RHEUMATISM
- A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
- (2013) Manfred Wirth et al. EUROPEAN UROLOGY
- Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab
- (2013) Bella Ungar et al. GUT
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
- (2013) M. Jani et al. RHEUMATOLOGY
- Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions
- (2013) Jose Ramon Maneiro et al. JAMA Internal Medicine
- Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
- (2013) Gary R. Lichtenstein Therapeutic Advances in Gastroenterology
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab
- (2012) Chamaida Plasencia et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of biosimilars in the treatment of rheumatic diseases
- (2012) Thomas Dörner et al. ANNALS OF THE RHEUMATIC DISEASES
- The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
- (2012) Sandra Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease
- (2012) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
- (2011) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis
- (2011) D. Pascual-Salcedo et al. RHEUMATOLOGY
- The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
- (2010) S. Ben-Horin et al. GUT
- Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
- (2010) Matthieu Allez et al. Journal of Crohns & Colitis
- Clinical concerns of immunogenicity produced at cellular levels by biopharmaceuticals following their parenteral administration into human body
- (2010) Shunmugaperumal Tamilvanan et al. JOURNAL OF DRUG TARGETING
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
- (2009) Andrea Cassinotti et al. INFLAMMATORY BOWEL DISEASES
- Immunological mechanism underlying the immune response to recombinant human protein therapeutics
- (2009) Melody Sauerborn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The implications of immunogenicity for protein-based multiple sclerosis therapies
- (2008) Bruce A. Cohen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More